Medical oncology (Northwood, London, England)

Keyphrases

Publications

volume 41, number 9, 2024

Liuxin Yang, Yudian Shao, Tingting Gao, Ousman Bajinka, Xingxing Yuan
Current advances in cancer energy metabolism under dietary restriction: a mini review. Medical oncology (Northwood, London, England) 41 (9) (2024)
Dania A Nava-Tapia, Norely Y Román-Justo, Antonio Cuenca-Rojo, Lizeth G Guerrero-Rivera, Annet Patrón-Guerrero, Ruth I Poblete-Cruz, Ana E Zacapala-Gómez, César Sotelo-Leyva, Napoleón Navarro-Tito, Miguel Angel Mendoza-Catalán
Exploring the potential of tocopherols: mechanisms of action and perspectives in the prevention and treatment of breast cancer. Medical oncology (Northwood, London, England) 41 (9) (2024)
Sukumar Kalvapudi, Akhil Goud Pachimatla, R J Seager, Jeffrey Conroy, Sarabjot Pabla, Sarbajit Mukherjee
Cancer/testis antigen expression and co-expression patterns in gastroesophageal adenocarcinoma. Medical oncology (Northwood, London, England) 41 (9) (2024)
Liuxin Yang, Yudian Shao, Tingting Gao, Ousman Bajinka, Xingxing Yuan
Current advances in cancer energy metabolism under dietary restriction: a mini review. Medical oncology (Northwood, London, England) 41 (9) (2024)
Asim Joshi, Abantika Ghosh, Prashant Rai, Sarika Tilwani, Venkataramanan Ramachandran, Kumar Prabhash, Mahul Amin, Prashant Kumar
Cabazitaxel as a promising therapy for cisplatin-resistant bladder cancer: a preliminary study. Medical oncology (Northwood, London, England) 41 (9) (2024)
Sunaina Bhuker, Avneet Kaur, Kanitha Rajauria, Hardeep Singh Tuli, Adesh K Saini, Reena V Saini, Madhu Gupta
Allicin: a promising modulator of apoptosis and survival signaling in cancer. Medical oncology (Northwood, London, England) 41 (9) (2024)
Liuxin Yang, Yudian Shao, Tingting Gao, Ousman Bajinka, Xingxing Yuan
Current advances in cancer energy metabolism under dietary restriction: a mini review. Medical oncology (Northwood, London, England) 41 (9) (2024)
Sukumar Kalvapudi, Akhil Goud Pachimatla, R J Seager, Jeffrey Conroy, Sarabjot Pabla, Sarbajit Mukherjee
Cancer/testis antigen expression and co-expression patterns in gastroesophageal adenocarcinoma. Medical oncology (Northwood, London, England) 41 (9) (2024)
Ehsan Mehrtabar, Amirreza Khalaji, Mojtaba Pandeh, Aram Farhoudian, Nadia Shafiee, Atefe Shafiee, Fatemeh Ojaghlou, Parinaz Mahdavi, Mehdi Soleymani-Goloujeh
Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review. Medical oncology (Northwood, London, England) 41 (9) (2024)
Bibhukalyan Mohapatra, Suresh B Pakala
Emerging roles of the chromatin remodeler MORC2 in cancer metabolism. Medical oncology (Northwood, London, England) 41 (9) (2024)
Liuxin Yang, Yudian Shao, Tingting Gao, Ousman Bajinka, Xingxing Yuan
Current advances in cancer energy metabolism under dietary restriction: a mini review. Medical oncology (Northwood, London, England) 41 (9) (2024)
Nourhan A Abou Madawi, Zeinab E Darwish, Enas M Omar
Targeted gene therapy for cancer: the impact of microRNA multipotentiality. Medical oncology (Northwood, London, England) 41 (9) (2024)
Dania A Nava-Tapia, Norely Y Román-Justo, Antonio Cuenca-Rojo, Lizeth G Guerrero-Rivera, Annet Patrón-Guerrero, Ruth I Poblete-Cruz, Ana E Zacapala-Gómez, César Sotelo-Leyva, Napoleón Navarro-Tito, Miguel Angel Mendoza-Catalán
Exploring the potential of tocopherols: mechanisms of action and perspectives in the prevention and treatment of breast cancer. Medical oncology (Northwood, London, England) 41 (9) (2024)
Dania A Nava-Tapia, Norely Y Román-Justo, Antonio Cuenca-Rojo, Lizeth G Guerrero-Rivera, Annet Patrón-Guerrero, Ruth I Poblete-Cruz, Ana E Zacapala-Gómez, César Sotelo-Leyva, Napoleón Navarro-Tito, Miguel Angel Mendoza-Catalán
Exploring the potential of tocopherols: mechanisms of action and perspectives in the prevention and treatment of breast cancer. Medical oncology (Northwood, London, England) 41 (9) (2024)
Ramya Rajendiran, Murali Santhoshkumar
Letter to the editor: Comment on "Anti-cancer potential of casein and its derivatives: novel strategies for cancer treatment". Medical oncology (Northwood, London, England) 41 (9) (2024)
Sunaina Bhuker, Avneet Kaur, Kanitha Rajauria, Hardeep Singh Tuli, Adesh K Saini, Reena V Saini, Madhu Gupta
Allicin: a promising modulator of apoptosis and survival signaling in cancer. Medical oncology (Northwood, London, England) 41 (9) (2024)
Makan Cheraghpour, Nayeralsadat Fatemi, Mahdi Shadnoush, Ghazaleh Talebi, Sascha Tierling, Luis G Bermúdez-Humarán
Immunomodulation aspects of gut microbiome-related interventional strategies in colorectal cancer. Medical oncology (Northwood, London, England) 41 (9) (2024)
Sukumar Kalvapudi, Akhil Goud Pachimatla, R J Seager, Jeffrey Conroy, Sarabjot Pabla, Sarbajit Mukherjee
Cancer/testis antigen expression and co-expression patterns in gastroesophageal adenocarcinoma. Medical oncology (Northwood, London, England) 41 (9) (2024)
Yasmin M Attia, Hamada Ahmed Mokhlis, Ahmed Ismail, Ahmed S Doghish, Mohamed H Sobhy, Sherif S Hassanein, Walaa A El-Dakroury, Amr D Mariee, Salama A Salama, Marwa Sharaky
2-methoxyestradiol sensitizes tamoxifen-resistant MCF-7 breast cancer cells via downregulating HIF-1α. Medical oncology (Northwood, London, England) 41 (9) (2024)
Fan Tang, Qingyang Cui
Diverse roles of aldolase enzymes in cancer development, drug resistance and therapeutic approaches as moonlighting enzymes. Medical oncology (Northwood, London, England) 41 (9) (2024)
Wardah Ashfaq, Khurram Rehman, Abubaker Shahid, Muhammad Numair Younis
Therapeutic response and safety of radioligand therapy with 177 Lu-PSMA-617 in metastatic castration-resistant prostate cancer patients. Medical oncology (Northwood, London, England) 41 (9) (2024)
Mano Chitra Karthikeyan, Chandhru Srinivasan, Kowsika Prabhakar, Priyadharshini Manogar, Abirami Jayaprakash, Antony Joseph Velanganni Arockiam
Doxorubicin downregulates cell cycle regulatory hub genes in breast cancer cells. Medical oncology (Northwood, London, England) 41 (9) (2024)
Ehsan Mehrtabar, Amirreza Khalaji, Mojtaba Pandeh, Aram Farhoudian, Nadia Shafiee, Atefe Shafiee, Fatemeh Ojaghlou, Parinaz Mahdavi, Mehdi Soleymani-Goloujeh
Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review. Medical oncology (Northwood, London, England) 41 (9) (2024)
YuHan Wang, YaLing Li, Jun Li
Comment on "Pharmacokinetic studies, molecular docking, and molecular dynamics simulations of phytochemicals from Morus alba: a multi-receptor approach for potential therapeutic agents in colorectal cancer". Medical oncology (Northwood, London, England) 41 (9) (2024)
Ahmad Kooshari, Fahimeh Shahriyary, Minoo Shahidi, Mahshid Vafajoo, Mohammad Reza Amirzargar
Tetrahydroisoquinoline reduces angiogenesis by interacting myeloma cells with HUVECs mediated by extracellular vesicles. Medical oncology (Northwood, London, England) 41 (9) (2024)
Sunaina Bhuker, Avneet Kaur, Kanitha Rajauria, Hardeep Singh Tuli, Adesh K Saini, Reena V Saini, Madhu Gupta
Allicin: a promising modulator of apoptosis and survival signaling in cancer. Medical oncology (Northwood, London, England) 41 (9) (2024)
Nilina James
Comment on 'Therapeutic targeting of TNIK in papillary thyroid carcinoma: a novel approach for tumor growth suppression'. Medical oncology (Northwood, London, England) 41 (9) (2024)
Jie Liu, Yung-Ting Chang, Yan-Yu Kou, Pei-Pei Zhang, Qing-Li Dong, Ruo-Yu Guo, Li-Yun Liu, Hou-Wen Lin, Fan Yang
Marine sponge-derived alkaloid inhibits the PI3K/AKT/mTOR signaling pathway against diffuse large B-cell lymphoma. Medical oncology (Northwood, London, England) 41 (9) (2024)
Neha Sylvia Walter, Shalmoli Bhattacharyya
Mining parasites for their potential as novel therapeutic agents against cancer. Medical oncology (Northwood, London, England) 41 (9) (2024)
Neha Sylvia Walter, Shalmoli Bhattacharyya
Mining parasites for their potential as novel therapeutic agents against cancer. Medical oncology (Northwood, London, England) 41 (9) (2024)
Jie Liu, Yung-Ting Chang, Yan-Yu Kou, Pei-Pei Zhang, Qing-Li Dong, Ruo-Yu Guo, Li-Yun Liu, Hou-Wen Lin, Fan Yang
Marine sponge-derived alkaloid inhibits the PI3K/AKT/mTOR signaling pathway against diffuse large B-cell lymphoma. Medical oncology (Northwood, London, England) 41 (9) (2024)
Yasmin M Attia, Hamada Ahmed Mokhlis, Ahmed Ismail, Ahmed S Doghish, Mohamed H Sobhy, Sherif S Hassanein, Walaa A El-Dakroury, Amr D Mariee, Salama A Salama, Marwa Sharaky
2-methoxyestradiol sensitizes tamoxifen-resistant MCF-7 breast cancer cells via downregulating HIF-1α. Medical oncology (Northwood, London, England) 41 (9) (2024)
Sunaina Bhuker, Avneet Kaur, Kanitha Rajauria, Hardeep Singh Tuli, Adesh K Saini, Reena V Saini, Madhu Gupta
Allicin: a promising modulator of apoptosis and survival signaling in cancer. Medical oncology (Northwood, London, England) 41 (9) (2024)
Majid Ghorbani, Mohammad Soukhtanloo, Amir Salek Farrokhi, Seyed Mahdi Hassanian, Fatemeh Ghorbani, Amir Reza Afshari, Mohsen Taherian, Mohammad Hadi Sadeghian
Correction to: Auraptene‑induced cytotoxic effects in acute myeloid leukemia cell Lines. Medical oncology (Northwood, London, England) 41 (9) (2024)
Dania A Nava-Tapia, Norely Y Román-Justo, Antonio Cuenca-Rojo, Lizeth G Guerrero-Rivera, Annet Patrón-Guerrero, Ruth I Poblete-Cruz, Ana E Zacapala-Gómez, César Sotelo-Leyva, Napoleón Navarro-Tito, Miguel Angel Mendoza-Catalán
Exploring the potential of tocopherols: mechanisms of action and perspectives in the prevention and treatment of breast cancer. Medical oncology (Northwood, London, England) 41 (9) (2024)
Yasmin M Attia, Hamada Ahmed Mokhlis, Ahmed Ismail, Ahmed S Doghish, Mohamed H Sobhy, Sherif S Hassanein, Walaa A El-Dakroury, Amr D Mariee, Salama A Salama, Marwa Sharaky
2-methoxyestradiol sensitizes tamoxifen-resistant MCF-7 breast cancer cells via downregulating HIF-1α. Medical oncology (Northwood, London, England) 41 (9) (2024)
Elizabeth Campione, David Doubblestein
2023 ACS - LANA lymphedema summit forward momentum; future steps in lymphedema management. Medical oncology (Northwood, London, England) 41 (9) (2024)
Yuefeng Shang, Tong Liu, Wenjing Wang
The potential of lenvatinib in breast cancer therapy. Medical oncology (Northwood, London, England) 41 (9) (2024)
Rita Silva-Reis, Vera L M Silva, Susana M Cardoso, Izabela Michalak, Mirosława Püsküllüoğlu, Daniela Calina, Javad Sharifi-Rad
Moscatilin, a potential therapeutic agent for cancer treatment: insights into molecular mechanisms and clinical prospects. Medical oncology (Northwood, London, England) 41 (9) (2024)
Ayşe Hale Alkan, Mine Ensoy, Demet Cansaran-Duman
A new therapeutic strategy for luminal A-breast cancer treatment: vulpinic acid as an anti-neoplastic agent induces ferroptosis and apoptosis mechanisms. Medical oncology (Northwood, London, England) 41 (9) (2024)
Majid Ghorbani, Mohammad Soukhtanloo, Amir Salek Farrokhi, Seyed Mahdi Hassanian, Fatemeh Ghorbani, Amir Reza Afshari, Mohsen Taherian, Mohammad Hadi Sadeghian
Correction to: Auraptene‑induced cytotoxic effects in acute myeloid leukemia cell Lines. Medical oncology (Northwood, London, England) 41 (9) (2024)
Nourhan A Abou Madawi, Zeinab E Darwish, Enas M Omar
Targeted gene therapy for cancer: the impact of microRNA multipotentiality. Medical oncology (Northwood, London, England) 41 (9) (2024)
Nawal Helmi, Abdullah Hamadi, Osama M Al-Amer, Hassan A Madkhali, Atif Abdulwahab A Oyouni, Amany I Alqosaibi, Jawaher Almulhim, Rashed Mohammed Alghamdi, Israa J Hakeem, Misbahuddin M Rafeeq
Unveiling the potency of FDA-approved oxidopamine HBr for cervical cancer regulation and replication proteins. Medical oncology (Northwood, London, England) 41 (9) (2024)
K L G Afeeza, S Balachandran, S Muthamizh, E Dilipan
Letters to editor regarding the article "P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway". Medical oncology (Northwood, London, England) 41 (9) (2024)
YuHan Wang, YaLing Li, Jun Li
Comment on "Pharmacokinetic studies, molecular docking, and molecular dynamics simulations of phytochemicals from Morus alba: a multi-receptor approach for potential therapeutic agents in colorectal cancer". Medical oncology (Northwood, London, England) 41 (9) (2024)
Nilina James
Comment on 'Therapeutic targeting of TNIK in papillary thyroid carcinoma: a novel approach for tumor growth suppression'. Medical oncology (Northwood, London, England) 41 (9) (2024)
Sukumar Kalvapudi, Akhil Goud Pachimatla, R J Seager, Jeffrey Conroy, Sarabjot Pabla, Sarbajit Mukherjee
Cancer/testis antigen expression and co-expression patterns in gastroesophageal adenocarcinoma. Medical oncology (Northwood, London, England) 41 (9) (2024)
Hanan Elimam, Sherif S Abdel Mageed, Abdulrahman Hatawsh, Rewan Moussa, Abdullah F Radwan, Nourhan Elfar, Nora A A Alhamshry, Mai A Abd-Elmawla, Osama A Mohammed, Mohamed Bakr Zaki, Ahmed S Doghish
Unraveling the influence of LncRNA in gastric cancer pathogenesis: a comprehensive review focus on signaling pathways interplay. Medical oncology (Northwood, London, England) 41 (9) (2024)
Nourhan A Abou Madawi, Zeinab E Darwish, Enas M Omar
Targeted gene therapy for cancer: the impact of microRNA multipotentiality. Medical oncology (Northwood, London, England) 41 (9) (2024)
Nourhan A Abou Madawi, Zeinab E Darwish, Enas M Omar
Targeted gene therapy for cancer: the impact of microRNA multipotentiality. Medical oncology (Northwood, London, England) 41 (9) (2024)